Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 9,437 | 8,983 | 7,763 | 4,787 | 4,820 |
| Gross Profit | 9,437 | 6,686 | 7,763 | 4,787 | 4,820 |
| Operating Expenses | 20,122 | 17,171 | 17,004 | 16,917 | 23,868 |
| Operating Income | -10,685 | -8,188 | -9,241 | -12,130 | -19,048 |
| Interest Expense | 2,100 | 2,131 | 1,465 | 1,421 | 1,470 |
| Other Income | -1,434 | 5,816 | -822 | -2,730 | -2,314 |
| Pre-tax Income | -14,219 | -4,503 | -11,528 | -16,281 | -22,832 |
| Net Income Continuous | -14,219 | -4,503 | -11,528 | -16,281 | -22,832 |
| Net Income | $-14,219 | $-4,503 | $-11,528 | $-16,281 | $-22,832 |
| EPS Basic Total Ops | -0.19 | -0.06 | -0.16 | -0.22 | -0.31 |
| EPS Basic Continuous Ops | -0.19 | -0.06 | -0.16 | -0.22 | -0.31 |
| EPS Diluted Total Ops | -0.19 | -0.06 | -0.16 | -0.22 | -0.31 |
| EPS Diluted Continuous Ops | -0.19 | -0.06 | -0.16 | -0.22 | -0.31 |
| EBITDA(a) | $-10,275 | $-7,769 | $-8,754 | $-11,862 | $-18,658 |